Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
U.K. Market Performance
7D7 Days: 2.1%
3M3 Months: 8.5%
1Y1 Year: 8.4%
YTDYear to Date: 9.0%
Over the past 7 days, the market has risen 2.1% with the Consumer Staples sector contributing the most to the gain. As for the past 12 months, the market is up 8.4%. Earnings are forecast to grow by 15% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...